Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs (Q46811016)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

8

object named as

Wim Jiskoot

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

6

object named as

Wim E Hennink

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

author name string

Maryam Amidi

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Hubert C Pellikaan

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Hoang Hirschberg

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Anne H de Boer

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Daan J A Crommelin

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Gideon Kersten

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

language of work or name

0 references

publication date

18 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

25

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

37-38

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

6818-6829

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

Alternative routes of insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Bronchus- and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

The lungs as a portal of entry for systemic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Lung mucosal immunity: immunoglobulin-A revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Immunoglobulin A: strategic defense initiative at the mucosal surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Neutralization of diphtheria toxin by human immunoglobulin classes and subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Intranasal vaccination against plague, tetanus and diphtheria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Formation of microparticulate protein powder using a supercritical fluid antisolvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

The formation of plasmid DNA loaded pharmaceutical powders using supercritical fluid technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Stabilization of proteins in dry powder formulations using supercritical fluid technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Molar-mass characterization of cationic polymers for gene delivery by aqueous size-exclusion chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Size analysis of suspension inhalation aerosols by inertial separation methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Aspects of the design and delivery of microparticles for vaccine applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Lung dendritic cells are primed by inhaled particulate antigens, and retain MHC class II/antigenic peptide complexes in hilar lymph nodes for a prolonged period of time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Prospects for the development of new vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Immune correlates of protection against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Neutralization of Sendai Virus by the IgG Subclass Antibodies of the Guinea Pig

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.064

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.05.064

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/17692440

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46811016&oldid=2133152746"